NCT00460512 An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended Release (ER) in Participants With Schizophrenia Status COMPLETED Phase PHASE3
NCT00458367 RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical Practice Status COMPLETED Phase N/A
NCT00458211 Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotics Status COMPLETED Phase PHASE4
NCT00458107 Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese and Non-Japanese Female Subjects Status COMPLETED Phase PHASE1
NCT00458094 Peer Support for Increasing Physical Activity in People With Serious Mental Illnesses Status COMPLETED Phase NA
NCT00457899 Rapid Versus Conventional Titration of Quetiapine in Schizophrenia/Schizoaffective Disorder Status TERMINATED Phase PHASE3
NCT00456976 Efficacy of Selegiline in Negative Symptoms of Schizophrenia Status COMPLETED Phase EARLY_PHASE1
NCT00455715 A Placebo-Controlled Single-Dose Trial of Sildenafil in Schizophrenia Status COMPLETED Phase PHASE4
NCT00455702 Effects of Weekly Dosing of D-cycloserine on Cognitive Function in Individuals With Schizophrenia Status COMPLETED Phase PHASE4
NCT00455663 Cognitive Adaptive Training for Improving Medication Adherence, Symptoms, and Function in People With Schizophrenia Status COMPLETED Phase NA
NCT00453804 Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI) Status COMPLETED Phase PHASE4
NCT00453609 Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI) Status COMPLETED Phase PHASE4
NCT00448890 Evaluation of Single and Repeat Doses of GSK729327 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT00448630 An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical Antipsychotics Status COMPLETED Phase N/A
NCT00445926 Evaluation of the H1-coil Deep TMS in the Treatment of Negative Symptoms and Cognitive Deficit in Schizophrenia Status COMPLETED Phase PHASE1